世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

単純ヘルペスウイルス治療の世界市場インサイト、2030年までの予測


Global Herpes Simplex Virus Treatment Market Insights, Forecast to 2030

HSV感染を含む性感染症(STI)の急増は、STI検査・治療の需要を促進している。さらに、性の健康の重要性に対する意識の高まりは、患者が自分の症状を管理し、感染のリスクを軽減しようとするため、HSV治療に対す... もっと見る

 

 

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ
2024年5月23日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら
英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。

日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


 

サマリー

HSV感染を含む性感染症(STI)の急増は、STI検査・治療の需要を促進している。さらに、性の健康の重要性に対する意識の高まりは、患者が自分の症状を管理し、感染のリスクを軽減しようとするため、HSV治療に対する需要の増加につながっている。このため、HSV感染症に関連するスティグマが減少し、症状の管理と感染リスクの低減に役立つ治療に対する需要が増加している。さらに、発展途上国における医療費の増加は、HSV治療を含む医療サービスへのアクセスを増加させた。これにより、医療へのアクセスが増加し、単純ヘルペスウイルス治療に対する需要が急増した。
世界の単純ヘルペスウイルス治療市場は、2024年の1億8,800万米ドルから2030年には2億1,100万米ドルに成長し、予測期間中の年間平均成長率(CAGR)は2.9%になると予測されている。

HSV感染を含む性感染症(STI)の急増が、STI検査・治療の需要を促進している。さらに、性の健康の重要性に対する意識の高まりは、患者が症状を管理し、感染のリスクを軽減しようとするため、HSV治療に対する需要の増加につながっている。このため、HSV感染症に関連するスティグマが減少し、症状の管理と感染リスクの低減に役立つ治療に対する需要が増加している。さらに、発展途上国における医療費の増加は、HSV治療を含む医療サービスへのアクセスを増加させた。このため、医療へのアクセスが増加し、単純ヘルペスウイルス治療の需要が急増した。

レポートの内容
本レポートでは、単純ヘルペスウイルス治療の世界市場、売上、収益、価格の概要を紹介します。2019年~2023年の過去の市場収益/販売データ、2024年の予測、2030年までのCAGR予測による世界市場動向の分析。
単純ヘルペスウイルス治療薬の主要生産者を調査し、主要地域・国の売上高も掲載しています。単純ヘルペスウイルス治療薬の今後の市場ポテンシャルと、この市場を様々なセグメントとサブセグメントに予測するための主要地域/国の注目点のハイライト。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他の国々の国別データと市場価値分析。

本レポートでは、単純ヘルペスウイルス治療薬の売上高、収益、市場シェア、主要メーカーの業界ランキングに焦点を当て、2019年から2024年までのデータを掲載しています。世界の単純ヘルペスウイルス治療市場における主要な利害関係者を特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づいて分析します。本レポートは、利害関係者が競争状況を理解し、より多くの洞察を得て、より良い方法で事業と市場戦略を位置づけるのに役立ちます。
本レポートでは、2019年から2030年までのタイプ別、用途別のセグメントデータ、売上高、収益、価格を分析しています。単純ヘルペスウイルス治療薬の売上高、予測成長動向、生産技術、用途、エンドユーザー産業の評価と市場規模の予測。
Viatris Inc、Abbott Laboratories、Teva Pharmaceutical Industries Ltd、GlaxoSmithKline Plc、Pfizer Inc、Novartis AG、Fresenius SE and Co.KGaA、Amneal Pharmaceuticals LLC、Glenmark Pharmaceuticals Limited、Emcure Pharmaceuticals Limitedなど。

市場セグメンテーション
企業別
ヴィアトリス
アボット・ラボラトリーズ
テバ・ファーマシューティカル・インダストリーズ社
グラクソ・スミスクライン Plc
ファイザー
ノバルティスAG
フレゼニウスSEおよびCo.KGaA
アムニール・ファーマシューティカルズLLC
グレンマーク・ファーマシューティカルズ・リミテッド
エムキュア・ファーマシューティカルズ・リミテッド
タイプ別セグメント
アシクロビル
バラシクロビル
ファムシクロビル
用途別セグメント
ドラッグストアおよび小売薬局
オンラインプロバイダー
病院薬局
地域別セグメント
米国およびカナダ
米国
カナダ
中国
アジア(中国を除く)
日本
韓国
中国 台湾
東南アジア
インド
オーストラリア
ヨーロッパ
ドイツ
フランス
英国
イタリア
ロシア
中東、アフリカ、中南米
ブラジル
メキシコ
トルコ
イスラエル
GCC諸国

各章の概要
第1章:報告書のスコープ、各市場セグメント(タイプ別、用途別など)の市場規模、今後の発展可能性などのエグゼクティブサマリーを紹介。市場の現状と、短期・中期・長期的な展開の可能性について、ハイレベルな見解を提供しています。
第2章:単純ヘルペスウイルス治療薬の世界、地域レベル、国レベルでの販売(消費)、収益各地域とその主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場スペース、生産能力などを紹介しています。
第3章:単純ヘルペスウイルス治療メーカーの競争環境、価格、売上高、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などを詳細に分析する。
第4章:タイプ別の様々な市場セグメントの分析を提供し、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーし、読者が異なる市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。
第5章:読者が異なる下流市場のブルーオーシャン市場を見つけるのを助けるために、各市場セグメントの売上高、収益、平均価格、発展の可能性をカバーする、アプリケーション別の様々な市場セグメントの分析を提供します。
第6章 北米(米国・カナダ):タイプ別、用途別、国別、セグメント別の売上高、収益。
第7章:ヨーロッパ:タイプ別、用途別、国別、セグメント別の売上高、収益。
第8章:中国:タイプ別、用途別、セグメント別の売上高、収益。
第9章:アジア(中国を除く):タイプ別、用途別、地域別、セグメント別の売上高、収益。
第10章:中東、アフリカ、中南米:タイプ別、用途別、国別、セグメント別の売上高、収益。
第11章:主要メーカーのプロファイルを提供し、製品の説明と仕様、単純ヘルペスウイルス治療薬の売上高、収益、価格、粗利益率、最近の開発など、市場の主要企業の基本的な状況を詳細に紹介する。
第12章:産業チェーン、販売チャネル、主要原材料、流通業者と顧客の分析。
第13章:市場力学、市場の最新動向、市場の推進要因と制限要因、業界のメーカーが直面する課題とリスク、業界の関連政策の分析を紹介する。
第14章:レポートの要点と結論。



ページTOPに戻る


目次

1 Study Coverage
1.1 Herpes Simplex Virus Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Herpes Simplex Virus Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Acyclovir
1.2.3 Valacyclovir
1.2.4 Famciclovir
1.3 Market by Application
1.3.1 Global Herpes Simplex Virus Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Drug Store and Retail Pharmacies
1.3.3 Online Providers
1.3.4 Hospital Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Herpes Simplex Virus Treatment Revenue Estimates and Forecasts 2019-2030
2.2 Global Herpes Simplex Virus Treatment Revenue by Region
2.2.1 Global Herpes Simplex Virus Treatment Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Herpes Simplex Virus Treatment Revenue by Region (2019-2024)
2.2.3 Global Herpes Simplex Virus Treatment Revenue by Region (2025-2030)
2.2.4 Global Herpes Simplex Virus Treatment Revenue Market Share by Region (2019-2030)
2.3 Global Herpes Simplex Virus Treatment Sales Estimates and Forecasts 2019-2030
2.4 Global Herpes Simplex Virus Treatment Sales by Region
2.4.1 Global Herpes Simplex Virus Treatment Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Herpes Simplex Virus Treatment Sales by Region (2019-2024)
2.4.3 Global Herpes Simplex Virus Treatment Sales by Region (2025-2030)
2.4.4 Global Herpes Simplex Virus Treatment Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Herpes Simplex Virus Treatment Sales by Manufacturers
3.1.1 Global Herpes Simplex Virus Treatment Sales by Manufacturers (2019-2024)
3.1.2 Global Herpes Simplex Virus Treatment Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Herpes Simplex Virus Treatment in 2023
3.2 Global Herpes Simplex Virus Treatment Revenue by Manufacturers
3.2.1 Global Herpes Simplex Virus Treatment Revenue by Manufacturers (2019-2024)
3.2.2 Global Herpes Simplex Virus Treatment Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Herpes Simplex Virus Treatment Revenue in 2023
3.3 Global Key Players of Herpes Simplex Virus Treatment, Industry Ranking, 2021 VS 2022
3.4 Global Herpes Simplex Virus Treatment Sales Price by Manufacturers (2019-2024)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Herpes Simplex Virus Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Herpes Simplex Virus Treatment, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Herpes Simplex Virus Treatment, Product Offered and Application
3.8 Global Key Manufacturers of Herpes Simplex Virus Treatment, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Herpes Simplex Virus Treatment Sales by Type
4.1.1 Global Herpes Simplex Virus Treatment Historical Sales by Type (2019-2024)
4.1.2 Global Herpes Simplex Virus Treatment Forecasted Sales by Type (2025-2030)
4.1.3 Global Herpes Simplex Virus Treatment Sales Market Share by Type (2019-2030)
4.2 Global Herpes Simplex Virus Treatment Revenue by Type
4.2.1 Global Herpes Simplex Virus Treatment Historical Revenue by Type (2019-2024)
4.2.2 Global Herpes Simplex Virus Treatment Forecasted Revenue by Type (2025-2030)
4.2.3 Global Herpes Simplex Virus Treatment Revenue Market Share by Type (2019-2030)
4.3 Global Herpes Simplex Virus Treatment Price by Type
4.3.1 Global Herpes Simplex Virus Treatment Price by Type (2019-2024)
4.3.2 Global Herpes Simplex Virus Treatment Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Herpes Simplex Virus Treatment Sales by Application
5.1.1 Global Herpes Simplex Virus Treatment Historical Sales by Application (2019-2024)
5.1.2 Global Herpes Simplex Virus Treatment Forecasted Sales by Application (2025-2030)
5.1.3 Global Herpes Simplex Virus Treatment Sales Market Share by Application (2019-2030)
5.2 Global Herpes Simplex Virus Treatment Revenue by Application
5.2.1 Global Herpes Simplex Virus Treatment Historical Revenue by Application (2019-2024)
5.2.2 Global Herpes Simplex Virus Treatment Forecasted Revenue by Application (2025-2030)
5.2.3 Global Herpes Simplex Virus Treatment Revenue Market Share by Application (2019-2030)
5.3 Global Herpes Simplex Virus Treatment Price by Application
5.3.1 Global Herpes Simplex Virus Treatment Price by Application (2019-2024)
5.3.2 Global Herpes Simplex Virus Treatment Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Herpes Simplex Virus Treatment Market Size by Type
6.1.1 US & Canada Herpes Simplex Virus Treatment Sales by Type (2019-2030)
6.1.2 US & Canada Herpes Simplex Virus Treatment Revenue by Type (2019-2030)
6.2 US & Canada Herpes Simplex Virus Treatment Market Size by Application
6.2.1 US & Canada Herpes Simplex Virus Treatment Sales by Application (2019-2030)
6.2.2 US & Canada Herpes Simplex Virus Treatment Revenue by Application (2019-2030)
6.3 US & Canada Herpes Simplex Virus Treatment Market Size by Country
6.3.1 US & Canada Herpes Simplex Virus Treatment Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Herpes Simplex Virus Treatment Revenue by Country (2019-2030)
6.3.3 US & Canada Herpes Simplex Virus Treatment Sales by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Herpes Simplex Virus Treatment Market Size by Type
7.1.1 Europe Herpes Simplex Virus Treatment Sales by Type (2019-2030)
7.1.2 Europe Herpes Simplex Virus Treatment Revenue by Type (2019-2030)
7.2 Europe Herpes Simplex Virus Treatment Market Size by Application
7.2.1 Europe Herpes Simplex Virus Treatment Sales by Application (2019-2030)
7.2.2 Europe Herpes Simplex Virus Treatment Revenue by Application (2019-2030)
7.3 Europe Herpes Simplex Virus Treatment Market Size by Country
7.3.1 Europe Herpes Simplex Virus Treatment Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Herpes Simplex Virus Treatment Revenue by Country (2019-2030)
7.3.3 Europe Herpes Simplex Virus Treatment Sales by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Herpes Simplex Virus Treatment Market Size by Type
8.1.1 China Herpes Simplex Virus Treatment Sales by Type (2019-2030)
8.1.2 China Herpes Simplex Virus Treatment Revenue by Type (2019-2030)
8.2 China Herpes Simplex Virus Treatment Market Size by Application
8.2.1 China Herpes Simplex Virus Treatment Sales by Application (2019-2030)
8.2.2 China Herpes Simplex Virus Treatment Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Herpes Simplex Virus Treatment Market Size by Type
9.1.1 Asia Herpes Simplex Virus Treatment Sales by Type (2019-2030)
9.1.2 Asia Herpes Simplex Virus Treatment Revenue by Type (2019-2030)
9.2 Asia Herpes Simplex Virus Treatment Market Size by Application
9.2.1 Asia Herpes Simplex Virus Treatment Sales by Application (2019-2030)
9.2.2 Asia Herpes Simplex Virus Treatment Revenue by Application (2019-2030)
9.3 Asia Herpes Simplex Virus Treatment Market Size by Region
9.3.1 Asia Herpes Simplex Virus Treatment Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Herpes Simplex Virus Treatment Revenue by Region (2019-2030)
9.3.3 Asia Herpes Simplex Virus Treatment Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Market Size by Type
10.1.1 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Market Size by Application
10.2.1 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Market Size by Country
10.3.1 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Corporate Profile
11.1 Viatris Inc
11.1.1 Viatris Inc Company Information
11.1.2 Viatris Inc Overview
11.1.3 Viatris Inc Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Viatris Inc Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Viatris Inc Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Information
11.2.2 Abbott Laboratories Overview
11.2.3 Abbott Laboratories Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Abbott Laboratories Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Laboratories Recent Developments
11.3 Teva Pharmaceutical Industries Ltd
11.3.1 Teva Pharmaceutical Industries Ltd Company Information
11.3.2 Teva Pharmaceutical Industries Ltd Overview
11.3.3 Teva Pharmaceutical Industries Ltd Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Teva Pharmaceutical Industries Ltd Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Pharmaceutical Industries Ltd Recent Developments
11.4 GlaxoSmithKline Plc
11.4.1 GlaxoSmithKline Plc Company Information
11.4.2 GlaxoSmithKline Plc Overview
11.4.3 GlaxoSmithKline Plc Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 GlaxoSmithKline Plc Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GlaxoSmithKline Plc Recent Developments
11.5 Pfizer Inc
11.5.1 Pfizer Inc Company Information
11.5.2 Pfizer Inc Overview
11.5.3 Pfizer Inc Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Pfizer Inc Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Inc Recent Developments
11.6 Novartis AG
11.6.1 Novartis AG Company Information
11.6.2 Novartis AG Overview
11.6.3 Novartis AG Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Novartis AG Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novartis AG Recent Developments
11.7 Fresenius SE and Co. KGaA
11.7.1 Fresenius SE and Co. KGaA Company Information
11.7.2 Fresenius SE and Co. KGaA Overview
11.7.3 Fresenius SE and Co. KGaA Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Fresenius SE and Co. KGaA Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Fresenius SE and Co. KGaA Recent Developments
11.8 Amneal Pharmaceuticals LLC
11.8.1 Amneal Pharmaceuticals LLC Company Information
11.8.2 Amneal Pharmaceuticals LLC Overview
11.8.3 Amneal Pharmaceuticals LLC Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Amneal Pharmaceuticals LLC Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Amneal Pharmaceuticals LLC Recent Developments
11.9 Glenmark Pharmaceuticals Limited
11.9.1 Glenmark Pharmaceuticals Limited Company Information
11.9.2 Glenmark Pharmaceuticals Limited Overview
11.9.3 Glenmark Pharmaceuticals Limited Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Glenmark Pharmaceuticals Limited Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Glenmark Pharmaceuticals Limited Recent Developments
11.10 Emcure Pharmaceuticals Limited
11.10.1 Emcure Pharmaceuticals Limited Company Information
11.10.2 Emcure Pharmaceuticals Limited Overview
11.10.3 Emcure Pharmaceuticals Limited Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Emcure Pharmaceuticals Limited Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Emcure Pharmaceuticals Limited Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Herpes Simplex Virus Treatment Industry Chain Analysis
12.2 Herpes Simplex Virus Treatment Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Herpes Simplex Virus Treatment Production Mode & Process
12.4 Herpes Simplex Virus Treatment Sales and Marketing
12.4.1 Herpes Simplex Virus Treatment Sales Channels
12.4.2 Herpes Simplex Virus Treatment Distributors
12.5 Herpes Simplex Virus Treatment Customers
13 Herpes Simplex Virus Treatment Market Dynamics
13.1 Herpes Simplex Virus Treatment Industry Trends
13.2 Herpes Simplex Virus Treatment Market Drivers
13.3 Herpes Simplex Virus Treatment Market Challenges
13.4 Herpes Simplex Virus Treatment Market Restraints
14 Key Findings in the Global Herpes Simplex Virus Treatment Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る


 

Summary

The surge in prevalence of sexually transmitted infections (STIs), including HSV infections, is driving demand for STIs testing and treatment. In addition, increase in awareness of the importance of sexual health is leading to increased demand for HSV treatments, as patients seek to manage their symptoms and reduce the risk of transmission. This has reduced the stigma associated with HSV infections and has led to increase in demand for treatments that helps to manage symptoms and reduce the risk of transmission. Furthermore, increase in healthcare expenditure in developing countries has increased access to healthcare services, including HSV treatment. This has increased the access to healthcare and surged the demand for herpes simplex virus treatment.
The global Herpes Simplex Virus Treatment market is projected to grow from US$ 1818 million in 2024 to US$ 2161 million by 2030, at a Compound Annual Growth Rate (CAGR) of 2.9% during the forecast period.

The surge in prevalence of sexually transmitted infections (STIs), including HSV infections, is driving demand for STIs testing and treatment. In addition, increase in awareness of the importance of sexual health is leading to increased demand for HSV treatments, as patients seek to manage their symptoms and reduce the risk of transmission. This has reduced the stigma associated with HSV infections and has led to increase in demand for treatments that helps to manage symptoms and reduce the risk of transmission. Furthermore, increase in healthcare expenditure in developing countries has increased access to healthcare services, including HSV treatment. This has increased the access to healthcare and surged the demand for herpes simplex virus treatment.

Report Includes
This report presents an overview of global market for Herpes Simplex Virus Treatment, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.
This report researches the key producers of Herpes Simplex Virus Treatment, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Herpes Simplex Virus Treatment, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Herpes Simplex Virus Treatment sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Herpes Simplex Virus Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type, and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Herpes Simplex Virus Treatment sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Viatris Inc, Abbott Laboratories, Teva Pharmaceutical Industries Ltd, GlaxoSmithKline Plc, Pfizer Inc, Novartis AG, Fresenius SE and Co. KGaA, Amneal Pharmaceuticals LLC, Glenmark Pharmaceuticals Limited, Emcure Pharmaceuticals Limited, etc.

Market Segmentation
By Company
Viatris Inc
Abbott Laboratories
Teva Pharmaceutical Industries Ltd
GlaxoSmithKline Plc
Pfizer Inc
Novartis AG
Fresenius SE and Co. KGaA
Amneal Pharmaceuticals LLC
Glenmark Pharmaceuticals Limited
Emcure Pharmaceuticals Limited
Segment by Type
Acyclovir
Valacyclovir
Famciclovir
Segment by Application
Drug Store and Retail Pharmacies
Online Providers
Hospital Pharmacies
Segment by region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Australia
Europe
Germany
France
U.K.
Italy
Russia
Middle East, Africa, Latin America
Brazil
Mexico
Turkey
Israel
GCC Countries

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Herpes Simplex Virus Treatment in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Herpes Simplex Virus Treatment manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, sales, and revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, sales, and revenue for each segment.
Chapter 8: China by Type, and by Application, sales, and revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, sales, and revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, sales, and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Herpes Simplex Virus Treatment sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.



ページTOPに戻る


Table of Contents

1 Study Coverage
1.1 Herpes Simplex Virus Treatment Product Introduction
1.2 Market by Type
1.2.1 Global Herpes Simplex Virus Treatment Market Size Growth Rate by Type, 2019 VS 2023 VS 2030
1.2.2 Acyclovir
1.2.3 Valacyclovir
1.2.4 Famciclovir
1.3 Market by Application
1.3.1 Global Herpes Simplex Virus Treatment Market Size Growth Rate by Application, 2019 VS 2023 VS 2030
1.3.2 Drug Store and Retail Pharmacies
1.3.3 Online Providers
1.3.4 Hospital Pharmacies
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Herpes Simplex Virus Treatment Revenue Estimates and Forecasts 2019-2030
2.2 Global Herpes Simplex Virus Treatment Revenue by Region
2.2.1 Global Herpes Simplex Virus Treatment Revenue by Region: 2019 VS 2023 VS 2030
2.2.2 Global Herpes Simplex Virus Treatment Revenue by Region (2019-2024)
2.2.3 Global Herpes Simplex Virus Treatment Revenue by Region (2025-2030)
2.2.4 Global Herpes Simplex Virus Treatment Revenue Market Share by Region (2019-2030)
2.3 Global Herpes Simplex Virus Treatment Sales Estimates and Forecasts 2019-2030
2.4 Global Herpes Simplex Virus Treatment Sales by Region
2.4.1 Global Herpes Simplex Virus Treatment Sales by Region: 2019 VS 2023 VS 2030
2.4.2 Global Herpes Simplex Virus Treatment Sales by Region (2019-2024)
2.4.3 Global Herpes Simplex Virus Treatment Sales by Region (2025-2030)
2.4.4 Global Herpes Simplex Virus Treatment Sales Market Share by Region (2019-2030)
2.5 US & Canada
2.6 Europe
2.7 China
2.8 Asia (excluding China)
2.9 Middle East, Africa and Latin America
3 Competition by Manufacturers
3.1 Global Herpes Simplex Virus Treatment Sales by Manufacturers
3.1.1 Global Herpes Simplex Virus Treatment Sales by Manufacturers (2019-2024)
3.1.2 Global Herpes Simplex Virus Treatment Sales Market Share by Manufacturers (2019-2024)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Herpes Simplex Virus Treatment in 2023
3.2 Global Herpes Simplex Virus Treatment Revenue by Manufacturers
3.2.1 Global Herpes Simplex Virus Treatment Revenue by Manufacturers (2019-2024)
3.2.2 Global Herpes Simplex Virus Treatment Revenue Market Share by Manufacturers (2019-2024)
3.2.3 Global Top 10 and Top 5 Companies by Herpes Simplex Virus Treatment Revenue in 2023
3.3 Global Key Players of Herpes Simplex Virus Treatment, Industry Ranking, 2021 VS 2022
3.4 Global Herpes Simplex Virus Treatment Sales Price by Manufacturers (2019-2024)
3.5 Analysis of Competitive Landscape
3.5.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.5.2 Global Herpes Simplex Virus Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Key Manufacturers of Herpes Simplex Virus Treatment, Manufacturing Base Distribution and Headquarters
3.7 Global Key Manufacturers of Herpes Simplex Virus Treatment, Product Offered and Application
3.8 Global Key Manufacturers of Herpes Simplex Virus Treatment, Date of Enter into This Industry
3.9 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Herpes Simplex Virus Treatment Sales by Type
4.1.1 Global Herpes Simplex Virus Treatment Historical Sales by Type (2019-2024)
4.1.2 Global Herpes Simplex Virus Treatment Forecasted Sales by Type (2025-2030)
4.1.3 Global Herpes Simplex Virus Treatment Sales Market Share by Type (2019-2030)
4.2 Global Herpes Simplex Virus Treatment Revenue by Type
4.2.1 Global Herpes Simplex Virus Treatment Historical Revenue by Type (2019-2024)
4.2.2 Global Herpes Simplex Virus Treatment Forecasted Revenue by Type (2025-2030)
4.2.3 Global Herpes Simplex Virus Treatment Revenue Market Share by Type (2019-2030)
4.3 Global Herpes Simplex Virus Treatment Price by Type
4.3.1 Global Herpes Simplex Virus Treatment Price by Type (2019-2024)
4.3.2 Global Herpes Simplex Virus Treatment Price Forecast by Type (2025-2030)
5 Market Size by Application
5.1 Global Herpes Simplex Virus Treatment Sales by Application
5.1.1 Global Herpes Simplex Virus Treatment Historical Sales by Application (2019-2024)
5.1.2 Global Herpes Simplex Virus Treatment Forecasted Sales by Application (2025-2030)
5.1.3 Global Herpes Simplex Virus Treatment Sales Market Share by Application (2019-2030)
5.2 Global Herpes Simplex Virus Treatment Revenue by Application
5.2.1 Global Herpes Simplex Virus Treatment Historical Revenue by Application (2019-2024)
5.2.2 Global Herpes Simplex Virus Treatment Forecasted Revenue by Application (2025-2030)
5.2.3 Global Herpes Simplex Virus Treatment Revenue Market Share by Application (2019-2030)
5.3 Global Herpes Simplex Virus Treatment Price by Application
5.3.1 Global Herpes Simplex Virus Treatment Price by Application (2019-2024)
5.3.2 Global Herpes Simplex Virus Treatment Price Forecast by Application (2025-2030)
6 US & Canada
6.1 US & Canada Herpes Simplex Virus Treatment Market Size by Type
6.1.1 US & Canada Herpes Simplex Virus Treatment Sales by Type (2019-2030)
6.1.2 US & Canada Herpes Simplex Virus Treatment Revenue by Type (2019-2030)
6.2 US & Canada Herpes Simplex Virus Treatment Market Size by Application
6.2.1 US & Canada Herpes Simplex Virus Treatment Sales by Application (2019-2030)
6.2.2 US & Canada Herpes Simplex Virus Treatment Revenue by Application (2019-2030)
6.3 US & Canada Herpes Simplex Virus Treatment Market Size by Country
6.3.1 US & Canada Herpes Simplex Virus Treatment Revenue by Country: 2019 VS 2023 VS 2030
6.3.2 US & Canada Herpes Simplex Virus Treatment Revenue by Country (2019-2030)
6.3.3 US & Canada Herpes Simplex Virus Treatment Sales by Country (2019-2030)
6.3.4 US
6.3.5 Canada
7 Europe
7.1 Europe Herpes Simplex Virus Treatment Market Size by Type
7.1.1 Europe Herpes Simplex Virus Treatment Sales by Type (2019-2030)
7.1.2 Europe Herpes Simplex Virus Treatment Revenue by Type (2019-2030)
7.2 Europe Herpes Simplex Virus Treatment Market Size by Application
7.2.1 Europe Herpes Simplex Virus Treatment Sales by Application (2019-2030)
7.2.2 Europe Herpes Simplex Virus Treatment Revenue by Application (2019-2030)
7.3 Europe Herpes Simplex Virus Treatment Market Size by Country
7.3.1 Europe Herpes Simplex Virus Treatment Revenue by Country: 2019 VS 2023 VS 2030
7.3.2 Europe Herpes Simplex Virus Treatment Revenue by Country (2019-2030)
7.3.3 Europe Herpes Simplex Virus Treatment Sales by Country (2019-2030)
7.3.4 Germany
7.3.5 France
7.3.6 U.K.
7.3.7 Italy
7.3.8 Russia
8 China
8.1 China Herpes Simplex Virus Treatment Market Size by Type
8.1.1 China Herpes Simplex Virus Treatment Sales by Type (2019-2030)
8.1.2 China Herpes Simplex Virus Treatment Revenue by Type (2019-2030)
8.2 China Herpes Simplex Virus Treatment Market Size by Application
8.2.1 China Herpes Simplex Virus Treatment Sales by Application (2019-2030)
8.2.2 China Herpes Simplex Virus Treatment Revenue by Application (2019-2030)
9 Asia (excluding China)
9.1 Asia Herpes Simplex Virus Treatment Market Size by Type
9.1.1 Asia Herpes Simplex Virus Treatment Sales by Type (2019-2030)
9.1.2 Asia Herpes Simplex Virus Treatment Revenue by Type (2019-2030)
9.2 Asia Herpes Simplex Virus Treatment Market Size by Application
9.2.1 Asia Herpes Simplex Virus Treatment Sales by Application (2019-2030)
9.2.2 Asia Herpes Simplex Virus Treatment Revenue by Application (2019-2030)
9.3 Asia Herpes Simplex Virus Treatment Market Size by Region
9.3.1 Asia Herpes Simplex Virus Treatment Revenue by Region: 2019 VS 2023 VS 2030
9.3.2 Asia Herpes Simplex Virus Treatment Revenue by Region (2019-2030)
9.3.3 Asia Herpes Simplex Virus Treatment Sales by Region (2019-2030)
9.3.4 Japan
9.3.5 South Korea
9.3.6 China Taiwan
9.3.7 Southeast Asia
9.3.8 India
9.3.9 Australia
10 Middle East, Africa and Latin America
10.1 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Market Size by Type
10.1.1 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Sales by Type (2019-2030)
10.1.2 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Revenue by Type (2019-2030)
10.2 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Market Size by Application
10.2.1 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Sales by Application (2019-2030)
10.2.2 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Revenue by Application (2019-2030)
10.3 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Market Size by Country
10.3.1 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Revenue by Country: 2019 VS 2023 VS 2030
10.3.2 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Revenue by Country (2019-2030)
10.3.3 Middle East, Africa and Latin America Herpes Simplex Virus Treatment Sales by Country (2019-2030)
10.3.4 Brazil
10.3.5 Mexico
10.3.6 Turkey
10.3.7 Israel
10.3.8 GCC Countries
11 Corporate Profile
11.1 Viatris Inc
11.1.1 Viatris Inc Company Information
11.1.2 Viatris Inc Overview
11.1.3 Viatris Inc Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.1.4 Viatris Inc Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Viatris Inc Recent Developments
11.2 Abbott Laboratories
11.2.1 Abbott Laboratories Company Information
11.2.2 Abbott Laboratories Overview
11.2.3 Abbott Laboratories Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.2.4 Abbott Laboratories Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Abbott Laboratories Recent Developments
11.3 Teva Pharmaceutical Industries Ltd
11.3.1 Teva Pharmaceutical Industries Ltd Company Information
11.3.2 Teva Pharmaceutical Industries Ltd Overview
11.3.3 Teva Pharmaceutical Industries Ltd Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.3.4 Teva Pharmaceutical Industries Ltd Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Teva Pharmaceutical Industries Ltd Recent Developments
11.4 GlaxoSmithKline Plc
11.4.1 GlaxoSmithKline Plc Company Information
11.4.2 GlaxoSmithKline Plc Overview
11.4.3 GlaxoSmithKline Plc Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.4.4 GlaxoSmithKline Plc Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 GlaxoSmithKline Plc Recent Developments
11.5 Pfizer Inc
11.5.1 Pfizer Inc Company Information
11.5.2 Pfizer Inc Overview
11.5.3 Pfizer Inc Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.5.4 Pfizer Inc Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Pfizer Inc Recent Developments
11.6 Novartis AG
11.6.1 Novartis AG Company Information
11.6.2 Novartis AG Overview
11.6.3 Novartis AG Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.6.4 Novartis AG Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 Novartis AG Recent Developments
11.7 Fresenius SE and Co. KGaA
11.7.1 Fresenius SE and Co. KGaA Company Information
11.7.2 Fresenius SE and Co. KGaA Overview
11.7.3 Fresenius SE and Co. KGaA Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.7.4 Fresenius SE and Co. KGaA Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Fresenius SE and Co. KGaA Recent Developments
11.8 Amneal Pharmaceuticals LLC
11.8.1 Amneal Pharmaceuticals LLC Company Information
11.8.2 Amneal Pharmaceuticals LLC Overview
11.8.3 Amneal Pharmaceuticals LLC Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.8.4 Amneal Pharmaceuticals LLC Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Amneal Pharmaceuticals LLC Recent Developments
11.9 Glenmark Pharmaceuticals Limited
11.9.1 Glenmark Pharmaceuticals Limited Company Information
11.9.2 Glenmark Pharmaceuticals Limited Overview
11.9.3 Glenmark Pharmaceuticals Limited Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.9.4 Glenmark Pharmaceuticals Limited Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Glenmark Pharmaceuticals Limited Recent Developments
11.10 Emcure Pharmaceuticals Limited
11.10.1 Emcure Pharmaceuticals Limited Company Information
11.10.2 Emcure Pharmaceuticals Limited Overview
11.10.3 Emcure Pharmaceuticals Limited Herpes Simplex Virus Treatment Sales, Price, Revenue and Gross Margin (2019-2024)
11.10.4 Emcure Pharmaceuticals Limited Herpes Simplex Virus Treatment Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Emcure Pharmaceuticals Limited Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Herpes Simplex Virus Treatment Industry Chain Analysis
12.2 Herpes Simplex Virus Treatment Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Herpes Simplex Virus Treatment Production Mode & Process
12.4 Herpes Simplex Virus Treatment Sales and Marketing
12.4.1 Herpes Simplex Virus Treatment Sales Channels
12.4.2 Herpes Simplex Virus Treatment Distributors
12.5 Herpes Simplex Virus Treatment Customers
13 Herpes Simplex Virus Treatment Market Dynamics
13.1 Herpes Simplex Virus Treatment Industry Trends
13.2 Herpes Simplex Virus Treatment Market Drivers
13.3 Herpes Simplex Virus Treatment Market Challenges
13.4 Herpes Simplex Virus Treatment Market Restraints
14 Key Findings in the Global Herpes Simplex Virus Treatment Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

 

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
お客様よりデータリソース社へ(通常は円払い)の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

03-3582-2531

電話お問合せもお気軽に

 

2024/11/14 10:27

156.77 円

166.04 円

201.95 円

ページTOPに戻る